Cartesian Therapeutics
RNAC
RNAC
65 hedge funds and large institutions have $66.5M invested in Cartesian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-7
Holders Change %
-9.72%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
19
Closed
13
Calls
$632K
Puts
–
Net Calls
+$632K
Net Calls Change
+$632K
Top Buyers
Top Sellers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$63.2K |
2 |
MB
2
MPM BioImpact
Boston,
Massachusetts
|
$7.13M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$1.26M |
4 |
AA
4
ALPS Advisors
Denver,
Colorado
|
$0 |
5 |
5
Goldman Sachs
New York
|
$0 |